SEC v. Bullard, et al. is a new complaint filed by the SEC in the District of Minnesota on August 27, 2021. The complaint alleges Jason Dodd Bullard and his wife Angela Romero-Bullard (the “Bullards”), the owners of Bullard Enterprises LLC (collectively “Defendants”), defrauded around 200 investors of approximately $17.6 million as part of a Ponzi scheme where the Bullards falsely claimed investors funds would be used to trade foreign currencies. The complaint alleges Defendants violated Section 17(a) of the Securities Act and Section 10(b) and Rule 10-b-5 of the Securities Exchange Act.
Healthcare & Life Sciences Private Equity Deal Tracker: 1315 Capital Acquires Homestead Smart Health Plans
1315 Capital has announced it has acquired Homestead Smart Health Plans.
Homestead Smart Health Plans, based in Philadelphia, operates in the reference-based pricing solutions market. It serves employers with a technology platform and service offerings, including third-party administration, reference-based pricing and stop-loss insurance.
1315 Capital, based in Philadelphia, is a healthcare-focused growth equity…
Healthcare & Life Sciences Private Equity Deal Tracker: Atlantic Street Capital Acquires Prestige Medical Imaging
Atlantic Street Capital has announced it has acquired Prestige Medical Imaging (PMI).
PMI, based in Newburgh, N.J., is a medical imaging solutions company providing equipment service, maintenance and support to hospitals, physician practices, ambulatory surgery centers and sports teams across the United States. Founded in 2003, the company describes itself as the “largest independent…
Corporate Campaign Contributions Are a Crime, Independent Expenditures Legitimate: Sixth Circuit Explains the Difference
The Sixth Circuit has upheld the felony conviction of a former state party chair for illegal campaign contributions by a corporation he owned, in a case that both serves as an important reminder of the prohibition on corporate contributions to federal campaigns and shows that the Justice Department may be stepping up criminal election law enforcement while the Federal Election Commission is consumed by deadlock.
Another Company Loses a Data Breach Investigation Work Product Claim
One might think that any company reasonably anticipates litigation after suffering a data breach, so the work product doctrine would almost inevitably protect its data breach investigation. But only a handful of companies have succeeded in claiming such protection.
In In re Rutter’s Data Security Breach Litigation, Civ. A. No. 1:20-CV-382, 2021 U.S. Dist.…
Healthcare & Life Sciences Private Equity Deal Tracker: Amulet Capital Acquires Remedy Health Media
Amulet Capital Partners has announced it has acquired Remedy Health Media.
Remedy, with offices in New York and Arlington, Va., is a digital health platform that serves patients, caregivers and healthcare providers. Its health information websites include healthcentral.com, thebody.com and patientpower.info.
Amulet, based in Greenwich, Conn., is a middle market private equity investment…
Healthcare & Life Sciences Private Equity Deal Tracker: Altaris Sells BK Medical to General Electric
Altaris Capital Partners has announced it has agreed to sell BK Medical to General Electric (NYSE:GE) for a cash purchase price of $1.45 billion.
BK Medical, with its U.S. headquarters in Boston, is a developer of intraoperative imaging and surgical navigation. Founded in 1992, the company’s solutions are used to guide clinicians during minimally…
Healthcare & Life Sciences Private Equity Deal Tracker: Audax Acquires GCX Mounting Solutions
Audax Private Equity has announced it has acquired GCX Mounting Solutions.
GCX, with its North American operations based out of Petaluma, Cali., is a global designer and manufacturer of healthcare-focused mounting and mobility solutions. Founded in 1971, the company’s products include wall mounts, roll stands, carts and a variety of mounting accessories.
Audax,…
Frequently Asked Questions About the New COVID-19 Vaccine Executive Actions
As McGuireWoods noted in a Sept. 10, 2021, alert, President Biden’s broad six-part strategy to combat the COVID-19 pandemic is raising many questions for employers. While employers await the much-anticipated regulations, a few answers to questions regarding the proposed federal vaccine requirements already are available.
For answers to frequently asked questions about the COVID-19…
Amulet Capital Partners Closes New Fund With $650 Million
Amulet Capital Partners has announced it has closed its second fund, Amulet Capital Partners II, in excess of $650 million in capital commitments.
The fund was oversubscribed, exceeding its initial target of $500 million.
Amulet Capital, based in Greenwich, Conn., is a middle market private equity investment firm focused exclusively on the healthcare sector.…